Education
About Us
Working with TipRanks
Follow Us
Biostax Corp (BTAX)
:BTAX
BTAX Stock Chart & Stats
Day’s Range― - ―
52-Week Range<$0.01 - $0.15
Previous CloseN/A
Volume10.00K
Average Volume (3M)0.00
Market Cap
$15.74K
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)2.89M
Price to Earnings (P/E)―
Beta2.12
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.02
Shares Outstanding78,713,630
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)11.40
P/FCF Ratio11.40
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
---
Biostax News
PremiumCompany Announcements
Biostax Voluntarily Delists from OTC Pink Marketplace---
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
BTAX FAQ
What was Biostax Corp’s price range in the past 12 months?
Biostax Corp lowest stock price was <$0.01 and its highest was $0.15 in the past 12 months.
What is Biostax Corp’s market cap?
Biostax Corp’s market cap is $15.74K.
When is Biostax Corp’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Biostax Corp’s earnings last quarter?
Biostax Corp released its earnings results on May 15, 2018. The company reported -$0.002 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.002.
Is Biostax Corp overvalued?
According to Wall Street analysts Biostax Corp’s price is currently Overvalued.
Does Biostax Corp pay dividends?
Biostax Corp does not currently pay dividends.
What is Biostax Corp’s EPS estimate?
Biostax Corp’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Biostax Corp have?
Biostax Corp has 78,713,630 shares outstanding.
What happened to Biostax Corp’s price movement after its last earnings report?
Biostax Corp reported an EPS of -$0.002 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same N/A.
Which hedge fund is a major shareholder of Biostax Corp?
Currently, no hedge funds are holding shares in BTAX
---
Company Description
Biostax Corp
Immune Therapeutics, Inc. is a biopharmaceutical company focuses on the commercialization of affordable non-toxic immunotherapies focused on the activation and rebalancing of the body's immune system. It specializes in the treatment of cancers, HIV, autoimmune diseases, inflammatory conditions, and other opportunistic infections for chronic often life-threatening diseases through the mobilization of the body's immune system in emerging nations using existing clinical data. The company was founded by Noreen Griffin on December 2, 1993 and is headquartered in Orlando, FL.
---
Technical Analysis
Scorpius Holdings
―
Salarius Pharmaceuticals
―
Processa Pharmaceuticals
―
GRI Bio
―
Onconetix
―
---